Open navigation
Search
Search

Select your region

Life Sciences & Healthcare

Latest

  • China Tightens Obligations of CMOs in Drug Contract Manufacturing
    12 Mar 2026 2 min read
  • China Tightens Obligations of CMOs in Drug Contract Manufacturing
    11 Mar 2026 1 min read
  • CMS ranked in Chambers Greater China Region Guide 2026
    16 Jan 2026 2 min read
  • China has Renewed the National Reimbursement Drug List and Released the First Commercial Reimbursement List for Innovative Drugs
    09 Jan 2026 7 min read
  • Medical technologies in defence and aerospace: Key themes and emerging questions in regulation
    09 Jan 2026 7 min read
  • China has Renewed the National Reimbursement Drug List and Released the First Commercial Reimbursement List for Innovative Drugs
    09 Jan 2026 7 min read
  • 2026 – Topics that may Concern You
    05 Jan 2026 1 min read
  • 2026 – Topics that may Concern You
    05 Jan 2026 1 min read

As a participant in the life sciences & healthcare industry, you know that discovery and innovation are key to finding lasting health solutions. Yet due to the highly regulated nature of the industry, you - a corporate, investor or start-up - must overcome complex administrative, compliance and liability hurdles before your products and services can come to market.

With more than 480 experts, patent attorneys, scientists and academics across CMS and the support of the Lifesciences Asia-Pacific Network (LAN), we understand the scientific and commercial as well as the legal imperatives affecting your business. Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics.

With active memberships in the major industry associations such as the Association of the British Healthcare Industries (ABHI), Association of the British Pharmaceutical Industry (ABPI), MedTech Europe, Bundesverband Medizintechnologie (BVMed) and the Hong Kong Association of the Pharmaceutical Industry (HKAPI), we help shape the legal frameworks impacting the life sciences sector. We regularly advise our clients on their day-to-day operational needs such as support with public sector procurement, patent prosecution and enforcement, commercial agreements, tax and transfer pricing, and regulatory advice. Equally, when you need life sciences specialist advice for strategic agreements, planning a corporate transaction or embarking on litigation (whether product liability or otherwise), we have a team that is well versed in the industry issues to help you.

Life Sciences & Healthcare Insights

CMS Expert Guide to advertising of medicines and medical devices

26 Mar 2026 2 min read

China Tightens Obligations of CMOs in Drug Contract Manufacturing

12 Mar 2026 2 min read

China Tightens Obligations of CMOs in Drug Contract Manufacturing

11 Mar 2026 1 min read

CMS ranked in Chambers Greater China Region Guide 2026

16 Jan 2026 2 min read

China has Renewed the National Reimbursement Drug List and Released the First Commercial Reimbursement List for Innovative Drugs

09 Jan 2026 7 min read

Medical technologies in defence and aerospace: Key themes and emerging questions in regulation

09 Jan 2026 7 min read

China has Renewed the National Reimbursement Drug List and Released the First Commercial Reimbursement List for Innovative Drugs

09 Jan 2026 7 min read

2026 – Topics that may Concern You

05 Jan 2026 1 min read

Events

  • China
    08 Apr 2026

    CMS at Fordham IP & Policy Conference

  • China
    21 Apr 2026

    On the Pulse webinar series 2026 - Spring/Summer

  • China
    28 Apr 2026

    IP Insights webinar series 2026

  • China
    02 May 2026

    CMS at INTA 2026

Back to top Back to top